How big is the Medical Diagnostics Market?
According to 6Wresearch internal database and industry insights, the Medical Diagnostics Market was valued at USD 66.4 Billion in 2024 and is projected to reach USD 104.7 Billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025–2031.
The market is expanding due to the increasing prevalence of chronic and infectious diseases, growing demand for early and accurate diagnosis, and rapid advancements in diagnostic technologies.
Key Growth Drivers of the Medical Diagnostics Market
- Rising incidence of chronic conditions such as cancer, diabetes, and cardiovascular diseases
- Technological advancements in molecular diagnostics and imaging techniques
- Increased government funding and awareness programs for early disease detection
- Expansion of point-of-care (POC) testing in remote and homecare settings
- Growth in aging population and healthcare expenditure worldwide
Medical Diagnostics Market Trends
The medical diagnostics market is witnessing increased adoption of AI-powered diagnostic platforms, especially in radiology and pathology. Next-generation sequencing (NGS) and molecular diagnostics, such as PCR, are also becoming a trend in the screening of infectious diseases and genetic pathologies. The decentralization of testing, which occurs in the form of portable and wearable diagnostic devices, is on the increase. Further combination of diagnostic information with electronic health records (EHRs) and online medical practices is increasingly being observed. Moreover, the market of oncology testing is being disrupted by liquid biopsy and biomarker-based diagnostics tests.
Emerging Developments in the Medical Diagnostics Market
The Medical Diagnostics market is evolving with the development of multiplexed and real-time diagnostic platforms that allow simultaneous testing of multiple diseases. Business firms are working on cost-efficient enhanced and quick tests to be applied in a low resource environment. Tele-pathology and tele-diagnostic services are trending, especially in the rural areas. Lab-on-a-chip devices (through microfluidics) are appearing to have faster, smaller more compact diagnostics. Moreover, the regulatory bodies are promoting the use of companion diagnostics to help underpin precision medicine efforts.
Major Companies in the Medical Diagnostics Market
- Abbott Laboratories
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Becton, Dickinson and Company
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Hologic, Inc.
- GE HealthCare Technologies Inc.
- Qiagen N.V.
How big is the Medical Diagnostics Market : FAQs
It was valued at USD 66.4 Billion in 2024 and is projected to reach USD 104.7 Billion by 2031.
The medical diagnostics market is expected to grow at a CAGR of 6.7% from 2025 to 2031.
Disease prevalence, demand for early diagnosis, and innovation in molecular and point-of-care diagnostics.
Imaging (MRI, CT, X-ray), in vitro diagnostics (IVD), molecular testing, and point-of-care testing.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com